AGN/PFE/RVNC—Addendum to the bottom paragraph of #msg-118089926: Botox is AGN’s largest and most profitable product by far, so RVNC’s data released today will surely play some role in the PFE-AGN merger discussions, possibly allowing PFE to negotiate a better price.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.